profile image

Dr. Madhukar Pai

Professor & Director of Global Health, McGill University

Prof Madhukar Pai, MD, PhD is a Canada Research Chair in Epidemiology & Global Health at McGill University, Montreal. He is the Director of McGill Global Health Programs, and Associate Director of the McGill International TB Centre.

Madhu Pai did his medical training and community medicine residency in Vellore, India. He completed his PhD in epidemiology at UC Berkeley, and a postdoctoral fellowship at the UCSF. Madhu serves as a Consultant to the Bill & Melinda Gates Foundation. He serves on the STAG-TB committee of WHO, Geneva; Scientific Advisory Committee of FIND, Geneva; and Access Advisory Committee of TB Alliance, New York. He has previously served on the Coordinating Board of the Stop TB Partnership. He is on the editorial boards of Lancet Infectious Diseases, PLoS Medicine, PLoS ONE, International Journal of TB and Lung Disease, among others. Madhu’s research is mainly focused on improving the diagnosis and treatment of tuberculosis, especially in high-burden countries like India and South Africa. His research is supported by grant funding from the Gates Foundation, Grand Challenges Canada, and Canadian Institutes of Health Research. He has more than 200 peer-reviewed publications. He is recipient of the Union Scientific Prize, Chanchlani Global Health Research Award, and Haile T. Debas Prize. He is a member of the Royal Society of Canada.

His book on tuberculosis can be accessed free at: www.letstalktb.org
Dr Jennifer Furin

Bridging The Gap Between Tuberculosis Innovation And Access

Never bring a knife to a gunfight. And yet, the global tuberculosis (TB) community has been doing precisely that for decades -- fighting a protracted battle with antiquated, inefficient tools, including an insensitive diagnostic (i.e. sputum microscopy), a low-efficacy vaccine (i.e. BCG), and drug regimens that have hardly changed for decades.
05/02/2017 09:54 EDT
Dr. Madhukar Pai

New Numbers On Tuberculosis Burden Must Galvanize India To Act

India continues to bear the brunt of the TB epidemic, with 2.8 of the 10.4 million new TB cases that occurred in 2015. TB is also a major killer of Indian people. The latest Global Burden of Disease estimates from Institute of Health Metrics and Evaluation, published earlier this month, show TB to be the sixth leading cause of deaths in India.
10/17/2016 05:19 EDT
OrangeDukeProductions via Getty Images

Predatory Conferences Undermine Science And Scam Academics

Credible scientific conferences, typically organized by major professional societies and research agencies, will invite researchers to present because of the caliber and validity of their work as judged by the candidate's peers. Given the importance of conferences in academia, predatory conference organizers sensed a business opportunity and started scamming researchers a few years ago.
10/13/2016 05:01 EDT